The Sept. 15, 2016, joint meeting of the NCATS Advisory Council and the Cures Acceleration Network Review Board featured the following meeting materials.
Presentations
- NCATS Director’s Report (PDF - 4MB) – Christopher P. Austin, M.D., director, NCATS
- Update on the CTSA Program and Office of Rare Diseases Research Toolkit Project (PDF - 1MB) – Petra Kaufmann, M.D., M.Sc., director, Office of Rare Diseases Research and Division of Clinical Innovation, NCATS
- Concept Clearance: NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (PDF - 71KB) – Christine M. Colvis, Ph.D., director of drug development partnership programs, Office of the Director, NCATS
- Concept Clearance: The CTSA Program Data to Health Initiative (PDF - 95KB) – Petra Kaufmann, M.D., M.Sc., director, Office of Rare Diseases Research and Division of Clinical Innovation, NCATS
- Illuminating the Druggable Genome: Program Overview (PDF - 536KB) – Christine M. Colvis, Ph.D., director of drug development partnership programs, Office of the Director, NCATS
- Illuminating the Druggable Genome: Recent Advances (PDF - 6MB) – Tudor I. Oprea, M.D., Ph.D., professor and chief, Division of Translational Informatics, Department of Internal Medicine, University of New Mexico School of Medicine
- Stimulating Peripheral Activity to Relieve Conditions: Program Update (PDF - 1MB) – Danilo A. Tagle, Ph.D., M.S., associate director for special initiatives, NCATS
Additional Meeting Information
- Agenda (PDF - 156KB)
- Minutes (PDF - 169KB)
- Videocast
- Federal Register Notice
- Concept Clearances